Tag: genomics
-
Companies to Analyze 40,000 Protein Samples
A partnership between genomic analysis company deCode Genetics and proteomics enterprise SomaLogic plans to analyze protein activity in 40,000 human samples.
-
Nanotech Gene Therapy Company Raises $8.5M in Seed Funds
A start-up company developing nanoscale particles to deliver gene-editing enzymes, including those for Crispr, is raising $8.5 million in its seed funding round.
-
RNA Biotech Raises $604M in IPO
Moderna Therapeutics, a biotechnology enterprise developing therapies with synthetic RNA, issued its initial public stock offering, or IPO, on Thursday, raising more than $604 million.
-
Report – 289 Cell and Gene Therapies in Development
A report by a pharmaceutical industry organization says nearly 300 new therapies that transfer live cells or genes as treatments for disease are in clinical trials or being reviewed by Food and Drug Administration.
-
Mount Sinai, Sanofi, Sema4 Partner on Long-Term Asthma Study
A collaboration of Mount Sinai medical center, drug maker Sanofi, and data science company Sema4 aims to track people with asthma for 5 years to help develop personalized treatments for the disease.
-
FDA Identifies Database to Evaluate Precision Diagnostics
The Food and Drug Administration identified a public database of genomics and diseases as a resource to assess new diagnostics tests using genetic data for precision medicine.
-
Trial Results Show Gene Transfers Reverse Sickle Cell Disease
Results from the first 2 participants in a clinical trial show transferring healthy genes to patients with sickle cell disease reverses symptoms of the disease that continues for up to 1 year.
-
Trials OK’d for Inherited Eye Disease Therapy with Crispr
The company developing a treatment for a rare inherited eye disease using the genome editing technique Crispr received authorization from the Food and Drug Administration to begin clinical trials.
-
Project to Catalog Precision Lung Cancer Immunotherapies
A new research initiative in the U.K. is collecting and mapping precise combinations of therapies that invoke the immune system to treat lung cancer.
-
Company Formed to Advance Sickle Cell Gene Therapy
A Swiss medical technologies company and Cincinnati Children’s hospital in Ohio are starting a new enterprise to commercialize research on gene therapies for inherited blood disorders.